Atlas Trials

Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer

Clinical trial NCT03539328 · UNKNOWN

Trial details

NCT number
NCT03539328
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2018-06-01
Primary completion
2022-04-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.